Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Cancer|February 11, 1992
Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancerP J Loehrer, S Rynard, R Ansari, et al.
Cancer|June 1, 1976
Oat cell carcinoma of the lung. Early treatment results of combination radiation therapy and chemotherapyN B Hornback, L Einhorn, H Shidnia, et al.
Cancer Research|May 15, 1994
Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic diseaseD Olivarez, T Ulbright, W DeRiese, et al.
Cancer|November 15, 1992
Phase III trial of cyclophosphamide versus cyclophosphamide, doxorubicin, and methotrexate in hormone-refractory prostatic cancer. A Hoosier Oncology Group studyS Saxman, R Ansari, R Drasga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2003
Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumorsA Madani, K Kemmer, C Sweeney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Prognostic factors for favorable outcome in disseminated germ cell tumorsR Birch, S Williams, A Cone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group TrialD W Luedke, L Einhorn, G A Omura, et al.
American Journal of Clinical Oncology|June 17, 1998
CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trialA Sandler, C Blanke, F Monaco, et al.
Seminars in Oncology|December 1, 1985
Metastatic breast cancer: preliminary results with oral hormonal therapyJ C Allegra, J Bertino, P Bonomi, et al.
The Journal of Urology|June 1, 1987
Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancerJ P Donohue, R G Rowland, K Kopecky, et al.
Pageof 5